Clearstate, Growth and Innovation Consulting the sceneexpertise clearly you thinking contact us
Innovation knowledge center Asia
 
Competitive strategy
 
state insights
white papers
media room
blog
subscribe
 
Best innovation white papers Asia


Here are some of our most recent white papers

Advances in spinal technologies: An Asian perspective (pdf)
Main drivers of growth are increased awareness of spinal disorder treatments, an increased GDP leading to higher government and patient spending power, increased usage of motor vehicles and machinery leading to rising number of trauma surgeries and lastly, an increase in obesity leading to back problems and injuries among the middle to high social class.
Flexible endoscopy and accessories - New opportunities and challenges in India (pdf)
Demand in India for flexible endoscopy remains at an all time high. Players with the right approach to the Indian market will reap most benefits.
Healthcare in the Middle East: An oasis of opportunities (pdf)
In the short span of a few decades, health care delivery in major Middle Eastern markets
(Saudi Arabia, United Arab Emirates, Kuwait) has developed from minimal to advanced
levels comparable to the West.
Biotech: India's new global pitch (pdf)
Research indicates that the India biotech Industry is on roll. Fueled by a growing domestic market, it has global ambitions. With revenues of USD2 billions in 2007, the India biotech industry has the capacity to grow 10 times in 10 years.
Thailand's healthcare tourism - Pain ahead? (pdf)
Thailand is facing tough competition from its Singapore neighbor. Fewer plastic surgery jobs in Singapore but many more open-heart operations. A 'cost-advantage' may not be an advantage after all.
Traditional Chinese Medicines: is there a market in the US? (pdf)
What is the potential for TCMs in the US? Can Asian OTC manufacturers secure market niches in the US, the largest global healthcare market? Ivy Teh, shares extracts of a recent presentation to the Singapore Government Clearstate provided.
China's Biotech Long March (pdf)
In 2003, the Chinese biotech market was valued at USD 3 billion. It is projected to reach USD 9 billion by 2010. Time to shift R&D biotech centers to China?
Why mergers fail: Beyond culture clashes (pdf)
When companies merge, they often highlight the potential 'synergies' to be gained from the merger. Recent research provides a framework for understanding when a merger is likely to be profitable.

bridging intelligence gaps in Healthcare